F05
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled for total endoprothetic hip Joint replacement were included
Exclusion criteria
Exclusion criteria: o Age <65 years o Pre-existing dementia o immunosuppression o Chronic skin diseases o Rejection by patients o Previous participation in this study o Drugaddicted patients , psychosis o Patients with heart pacemaker and deep brain stimulation o Existing anticholinergic medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative delirium after total hip joint replacement Preoperative, when transferred from the recovery room and 24 h and 48 h postoperatively, the Delire estimation is performed according to the "Confusion Assessment Method" for intensive care units (CAM-ICU) | — |
Secondary
| Measure | Time frame |
|---|---|
| o Activity of acetylcholineestrase (ACHE) and butyrylcholinesterase (BCHE) in the blood o Determination TNFa, NSE, S-100 ß protein o Epigenetic markers such as DNA methylation, acetylation, and histone modifications o Hospital lenght of stay These analyses are made at 4 times (during premedication, directly postoperatively, first and second postoperative day) with 15 ml of venous whole blood. | — |
Countries
Germany
Contacts
Universitätsklinikum Knappschaftskrankenhaus Bochum, Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie